Journal Article Review Epublish 71 citations
PubMed: 36124445 DOI: 10.17305/bjbms.2022.7762
SARS-CoV-2 infection and multi-organ system damage: A review.
Biomol Biomed 23(1):37-52
Authors: Ali A Rabaan, Samira Smajlović, Huseyin Tombuloglu, Sabahudin Ćordić, Azra Hajdarević, Nudžejma Kudić, Abbas Al Mutai, Safaa A Turkistani, Shamsah H Al-Ahmed, Nisreen A Al-Zaki, Mona J Al Marshood, Amal H Alfaraj, Saad Alhumaid, Ebtesam Al-Suhaimi
Affiliations
- Molecular Diagnostic Laboratory, Johns Hopkins Aramco Healthcare, Saudi Arabia.
- Laboratory Diagnostics Institute Dr. Dedić, Bosnia and Herzegovina.
- Department of Genetics Research, Institute for Research and Medical Consultations (IRMC), Imam Abdulrahman Bin Faisal University, Saudi Arabia.
- Cantonal hospital "Dr. Irfan Ljubijankić", Microbiological laboratory, Bosnia and Herzegovina.
- Department of Genetics and Bioengineering, Faculty of Engineering and Natural Sciences, International Burch University, Ilidža, Bosnia and Herzegovina.
- Faculty of Agriculture and Food Science, University of Sarajevo, Sarajevo, Bosnia and Herzegovina.
- Research Center, Almoosa Specialist Hospital, Saudi Arabia.
- Fakeeh College for Medical Science, Saudi Arabia.
- Specialty Pediatric Medicine, Qatif Central Hospital, Saudi Arabia.
- Pediatric Department, Abqaiq General Hospital, First Eastern Health Cluster, Saudi Arabia.
- Administration of Pharmaceutical Care, Al-Ahsa Health Cluster, Ministry of Health, Saudi Arabia.
- Biology Department, College of Science and Institute for Research and Medical Consultations (IRMC), Imam Abdulrahman Bin Faisal University, Saudi Arabia.
Abstract
The SARS-CoV-2 infection causes COVID-19, which has affected approximately six hundred million people globally as of August 2022. Organs and cells harboring angiotensin-converting enzyme 2 (ACE2) surface receptors are the primary targets of the virus. However, once it enters the body through the respiratory system, the virus can spread hematogenously to infect other body organs. Therefore, COVID-19 affects many organs, causing severe and long-term complications, even after the disease has ended, thus worsening the quality of life. Although it is known that the respiratory system is most affected by the SARS-CoV-2 infection, many organs/systems are affected in the short and long term. Since the COVID-19 disease simultaneously affects many organs, redesigning diagnostic and therapy policies to fit the damaged organs is strongly recommended. Even though the pathophysiology of many problems the infection causes is unknown, the frequency of COVID-19 cases rises with age and the existence of preexisting symptoms. This study aims to update our knowledge of SARS-CoV-2 infection and multi-organ dysfunction interaction based on clinical and theoretical evidence. For this purpose, the study comprehensively elucidates the most recent studies on the effects of SARS-CoV-2 infection on multiple organs and systems, including respiratory, cardiovascular, gastrointestinal, renal, nervous, endocrine, reproductive, immune, and parts of the integumentary system. Understanding the range of atypical COVID-19 symptoms could improve disease surveillance, limit transmission, and avoid additional multi-organ-system problems.
MeSH
Infections, Biomedical Research, Respiratory System, Sars Virus, Multiple Chronic Conditions, Angiotensin-Converting Enzyme 2, Covid-19, Sars-Cov-2
Cited by
- Genetics of Long COVID: Exploring the Molecular Drivers of Persistent Pulmonary Vascular Disease Symptoms. Infect Dis Rep, 2025
- Association between COVID-19 and the development of chronic kidney disease in patients without initial acute kidney injury. Sci Rep, 2025
- Association Between Vitamin A and D Status and the Risk of COVID-19 in the Elderly Population: A Single-Center Experience. J Inflamm Res, 2025
- Anti-interferon armamentarium of human coronaviruses. Cell Mol Life Sci, 2025
- From New Endocrine Entities Requiring New Approaches to New Approaches Leading to New Endocrine Entities. Diagnostics (Basel), 2023
- The clinical characteristics of pediatric patients infected by SARS-CoV-2 Omicron variant and whole viral genome sequencing analysis. PLoS One, 2023
- Three-Year Follow-Up of COVID-19 Cases in District of Constance, Germany. A Prospective, Controlled Cohort Study (FSC19-KN). J Clin Med, 2025
- Persisting Shadows: Unraveling the Impact of Long COVID-19 on Respiratory, Cardiovascular, and Nervous Systems. Infect Dis Rep, 2023
- Heparan sulfate proteoglycans remodel SARS-CoV-2 spike conformation to allow integrin interaction and infection of endothelial cells. Front Cell Infect Microbiol, 2025
- Comparison of DNA extraction methods for COVID-19 host genetics studies. PLoS One, 2023
- Elimination of olfactory sensory neurons by zinc sulfate inoculation prevents SARS-CoV-2 infection of the brain in K18-hACE2 transgenic mice. Sci Rep, 2024
- Longitudinal transcriptional changes reveal genes from the natural killer cell-mediated cytotoxicity pathway as critical players underlying COVID-19 progression. Elife, 2024
- COVID-19 and its association with meteorological, climate, and environmental factors: A systematic review. J Public Health Res, 2025
- A prevalence study of COVID-19 among healthcare workers in a pandemic hospital in the Samsun province of Turkey. PLoS One, 2022
- TMPRSS2 polymorphism (rs12329760) and the severity of the COVID-19 in Iranian population. PLoS One, 2023
- COVID-19 and Alzheimer's disease: Impact of lockdown and other restrictive measures during the COVID-19 pandemic. Biomol Biomed, 2024
- Dose-response effect between the number of long COVID symptoms and the use of different health services. Sci Rep, 2025
- Rhabdomyolysis secondary to COVID-19 infection and vaccination: a review of literature. Front Med (Lausanne), 2024
- Delivery strategies for RNA-targeting therapeutic nucleic acids and RNA-based vaccines against respiratory RNA viruses: IAV, SARS-CoV-2, RSV. Mol Ther Nucleic Acids, 2025
- Trends in symptom prevalence and sequential onset of SARS-CoV-2 infection from 2020 to 2022 in East and Southeast Asia: a trajectory pattern exploration based on summary data. Arch Public Health, 2024